Home » Stocks » Integra LifeSciences

Integra LifeSciences Holdings Corporation (IART)

Stock Price: $50.82 USD -0.35 (-0.68%)
Updated Aug 12, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 4.28B
Revenue (ttm) 1.39B
Net Income (ttm) -3.48M
Shares Out 84.27M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE 26.32
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 12, 2020
Last Price $50.82
Previous Close $51.17
Change ($) -0.35
Change (%) -0.68%
Day's Open 52.18
Day's Range 50.15 - 52.18
Day's Volume 542,210
52-Week Range 34.21 - 64.24

More Stats

Market Cap 4.28B
Enterprise Value 5.59B
Earnings Date (est) Oct 22, 2020
Ex-Dividend Date n/a
Shares Outstanding 84.27M
Float 71.24M
EPS (basic) -0.03
EPS (diluted) -0.04
FCF / Share 1.78
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 3.53%
Payout Ratio n/a
Shares Short 3.81M
Short Ratio 8.81
Short % of Float 5.44%
Beta 1.06
PE Ratio n/a
Forward PE 26.32
P/FCF Ratio 28.34
PS Ratio 3.09
PB Ratio 3.20
Revenue 1.39B
Operating Income 56.68M
Net Income -3.48M
Free Cash Flow 151.14M
Net Cash -1.30B
Net Cash / Share -15.47
Gross Margin 70.51%
Operating Margin 4.09%
Profit Margin -0.30%
FCF Margin 10.90%
ROA 4.64%
ROE 1.94%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (14)

Buy 7
Overweight 0
Hold 6
Underweight 1
Sell 0

Analyst Consensus: Overweight

Price Target

$58.08*
(14.29% upside)
Low
53.0
Current: $50.82
High
68.0
Target: 58.08
*Average 12-month price target from 12 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue1,5181,4721,188992883797697831780732
Revenue Growth3.06%23.92%19.77%12.39%10.8%14.33%-16.13%6.51%6.56%-
Gross Profit953901753643556494417516481464
Operating Income93.7611144.8011579.5967.8635.3773.7854.9198.69
Net Income50.2060.8064.7474.56-3.5234.00-21.0741.2027.9965.67
Shares Outstanding85.6482.8676.9074.3968.9964.8656.8356.4657.9059.10
Earnings Per Share0.580.720.820.94-0.050.52-0.370.720.481.09
EPS Growth-19.44%-12.2%-12.77%----51.58%-56.22%-
Operating Cash Flow23120011511610583.5753.2759.10104106
Capital Expenditures-69.50-77.32-43.21-47.01-31.98-38.34-41.77-69.03-38.43-37.14
Free Cash Flow16212271.3369.3972.8845.2311.50-9.9365.9068.43
Cash & Equivalents19913917510252.2171.7312196.94101129
Total Debt1,4581,3541,841665714630392520532403
Net Cash / Debt-1,259-1,215-1,666-563-662-558-271-423-431-275
Assets3,3033,1083,2111,8081,7741,5871,1921,1641,1441,019
Liabilities1,8871,7322,2499681,023883526646651519
Book Value1,4171,376962840751704666518493500
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Integra LifeSciences Holdings Corporation
Country United States
Employees 4,000
CEO Peter J. Arduini

Stock Information

Ticker Symbol IART
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier NASDAQ: IART
IPO Date August 16, 1995

Description

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. It operates in two segments, Codman Specialty Surgical, and Orthopedics and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, hydrocephalus management systems, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it sells hardware products, such as bone and joint fixation, and joint replacement devices; and implants and instruments, which provide for the orthopedic reconstruction of bone in the hand, wrist, elbow, and shoulder, as well as the foot, ankle, and leg below the knee in the extremity bone and joint reconstruction procedures. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was founded in 1989 and is headquartered in Princeton, New Jersey.